Current and Future Biomarkers in Gastric Gastroesophageal and Colorectal Adenocarcinoma 2024

Course Overview

Objectives:

1. Understand the current biomarker landscape in gastric/gastroesophageal and colorectal cancer
2. Understand the implications of biomarker studies on the prognosis and treatment of gastric/gastroesophageal and colorectal cancer
3. Understand what biomarkers will be available in the future and their implications on gastric/gastroesophageal and colorectal cancer

Needs:

1. New advances in pathologic analysis
2. New methods of diagnosis or treatment
3. Development of new technology
4. Advances in medical knowledge

References:

1. Nakamura Y, et al. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm. Nat Rev Clin Oncol. 2021;18:473-487.
2. Ivanova M, et al. HER2 in metastatic colorectal cancer: pathology, somatic alterations, and perspectives for novel therapeutic schemes. Life. 2022;12:1403.

Core Competencies: 2,3,6,7